GlassScriptPhysician profile
Michael B Bradley
NPI 1457461733
$997.78
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $30.69 · 2021: $158 · 2022: $273 · 2023: $274 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $190.34 | 2019-2023 | |
| Alcon Vision LLC | $153.17 | 2022-2024 | Rocklatan |
| Allergan, INC. | $115.93 | 2019-2022 | |
| Oyster Point Pharma, INC. | $72.47 | 2023-2024 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $60.63 | 2023-2024 | Acthar |
| Aerie Pharmaceuticals, INC. | $50.00 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $45.28 | 2021 | |
| Bausch & Lomb Americas INC. | $39.37 | 2023 | Envista Mx60 Iol, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $37.95 | 2019 | |
| Abbvie INC. | $34.36 | 2023-2024 | Durysta |
| Horizon Therapeutics Plc | $31.84 | 2023 | Tepezza |
| Glaukos Corporation | $24.99 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $23.38 | 2024 | Xdemvy |
| Rayner Intraocular Lenses Limited | $19.63 | 2022 | |
| Amgen INC. | $18.55 | 2024 | Tepezza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.18 | 2019 | |
| Biotissue Holdings INC. | $18.16 | 2021 | |
| Merz Pharmaceuticals, LLC | $16.52 | 2023 | Xeomin |
| Ocular Therapeutix, INC. | $14.52 | 2022 | |
| Pfizer INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.